Search research articles
Contact Us
Filters
Showing results (1-10 of 4) with videos related to
Page
of 1
Sort By:
Journal of Medicinal Chemistry
|
November 4, 2014
Asymmetric binding to NS5A by daclatasvir (BMS-790052) and analogs suggests two novel modes of HCV inhibition
James H Nettles, Richard A Stanton, Joshua Broyde, et al.
Nature Communications
|
July 5, 2023
UHRF1 is a mediator of KRAS driven oncogenesis in lung adenocarcinoma
Kaja Kostyrko, Marta Román, Alex G Lee, et al.
Nature Biotechnology
|
September 15, 2020
Oncoprotein-specific molecular interaction maps (SigMaps) for cancer network analyses
Joshua Broyde, David R Simpson, Diana Murray, et al.
Cell Stem Cell
|
April 9, 2016
Dclk1 Defines Quiescent Pancreatic Progenitors that Promote Injury-Induced Regeneration and Tumorigenesis
C Benedikt Westphalen, Yoshihiro Takemoto, Takayuki Tanaka, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 4) with videos related to
Sort By:
Page
of 1
Journal of Medicinal Chemistry
|
November 4, 2014
Asymmetric binding to NS5A by daclatasvir (BMS-790052) and analogs suggests two novel modes of HCV inhibition
James H Nettles, Richard A Stanton, Joshua Broyde, et al.
Nature Communications
|
July 5, 2023
UHRF1 is a mediator of KRAS driven oncogenesis in lung adenocarcinoma
Kaja Kostyrko, Marta Román, Alex G Lee, et al.
Nature Biotechnology
|
September 15, 2020
Oncoprotein-specific molecular interaction maps (SigMaps) for cancer network analyses
Joshua Broyde, David R Simpson, Diana Murray, et al.
Cell Stem Cell
|
April 9, 2016
Dclk1 Defines Quiescent Pancreatic Progenitors that Promote Injury-Induced Regeneration and Tumorigenesis
C Benedikt Westphalen, Yoshihiro Takemoto, Takayuki Tanaka, et al.
Page
of 1